Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Urothelial Cancer × Radiotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 39 Lung Neoplasms 31 Glioblastoma 22 Head and Neck Neoplasms 21 Squamous Cell Carcinoma of Head and Neck 19 Lymphoma 17 Breast Neoplasms 17 Brain Neoplasms 16 Rectal Neoplasms 14 Lymphoma, Non-Hodgkin 14 Leukemia, Lymphocytic, Chronic, B-Cell 13 Leukemia 13 Prostatic Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma, Follicular 11 Gliosarcoma 11 Central Nervous System Neoplasms 11 Lymphoma, Large B-Cell, Diffuse 10 Hodgkin Disease 10 Esophageal Neoplasms 10 Adenocarcinoma Of Esophagus 10 Pancreatic Neoplasms 9 Multiple Myeloma 9 Neoplasms, Plasma Cell 8 Neoplasm Metastasis 8 Melanoma 8 Lymphoma, B-Cell, Marginal Zone 8 Leukemia, Myeloid, Acute 8 Burkitt Lymphoma 8 Sarcoma 7

Interventions

durvalumab 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02891161 2024-11-27

DUART

Big Ten Cancer Research Consortium

Phase 1/2 Terminated

26 enrolled 20 charts

Urothelial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡